Barry D. Quart - 09 Jun 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
Director
Signature
/s/ Madelyn Zeylikman, Attorney-in-Fact
Issuer symbol
KNSA
Transactions as of
09 Jun 2025
Net transactions value
-$728,699
Form type
4
Filing time
11 Jun 2025, 17:35:55 UTC
Previous filing
05 Jun 2025
Next filing
17 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Quart Barry D Director 23 OLD BOND STREET, THIRD FLOOR, LONDON, UNITED KINGDOM /s/ Madelyn Zeylikman, Attorney-in-Fact 11 Jun 2025 0001384243

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Options Exercise $26,220 +6,900 +55% $3.80 19,446 09 Jun 2025 Direct
transaction KNSA Class A Ordinary Share Sale $208,794 -6,900 -35% $30.26 12,546 09 Jun 2025 Direct
transaction KNSA Class A Ordinary Share Options Exercise $31,206 +8,212 +65% $3.80 20,758 10 Jun 2025 Direct
transaction KNSA Class A Ordinary Share Sale $249,316 -8,212 -40% $30.36 12,546 10 Jun 2025 Direct F1
transaction KNSA Class A Ordinary Share Options Exercise $46,877 +12,336 +98% $3.80 24,882 11 Jun 2025 Direct
transaction KNSA Class A Ordinary Share Sale $374,891 -12,336 -50% $30.39 12,546 11 Jun 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KNSA Share Option Options Exercise $0 -6,900 -25% $0.000000 20,548 09 Jun 2025 Class A Ordinary Share 6,900 $3.80 Direct F3
transaction KNSA Share Option Options Exercise $0 -8,212 -40% $0.000000 12,336 10 Jun 2025 Class A Ordinary Shares 8,212 $3.80 Direct F3
transaction KNSA Share Option Options Exercise $0 -12,336 -100% $0.000000 0 11 Jun 2025 Class A Ordinary Shares 12,336 $3.80 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.00 and $30.52. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging between $30.28 and $30.5801. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3 The option is fully vested and exercisable.